Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.
Mind Body Globe on MSN
Why I Don't Take Overnight Buses Anymore - and Why You May Want to Rethink Them
Standing at the station at midnight, watching other passengers board what looked like a perfectly normal charter bus, I had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback